| Literature DB >> 32954211 |
Enrico Giustiniano1, Fabio Fazzari2, Renato Maria Bragato2, Mirko Curzi2, Maurizio Cecconi1,3.
Abstract
During SARS-CoV-2 pandemic, several subjects were treated in our intensive care unit (ICU) because of acute respiratory failure following COVID-19 pneumonia. Most of them required mechanical ventilation and someone in prone position (PP) too, because of acute respiratory distress syndrome (ARDS). During PP, trans-esophageal echocardiography (TEE) is not always easy, mainly due to the forced position of the neck of the patient. Moreover, during a pandemic, given the great number of patients needing treatment, TEE probes and monitoring devices are not widely available. Then, trans-thoracic echocardiography (TTE) plays a crucial role as it is non-invasive, repeatable, and available every time it is needed. Moreover, it can be safely performed also in prone position (TTEp). According to in-hospital protocol, TTEp was performed using the apical-four-chamber (A-4-C) view in 8 patients. We temporarily deflated the lower thoracic section of the air-mattress to place the probe between the mattress surface and the thorax of the patient. We collected both TEE and hemodynamics data. The main result of our retrospective analysis is that TTE can be performed in patients in prone positioning and is reliable and repeatable; the single apical-four-chamber view provides sufficient data to evaluate the cardiac performance in case of scarce availability of hemodynamic monitoring devices, like in a pandemic setting. TTE may be a helpful tool for cardiac performance evaluation and diagnosis not only in supine or anterolateral positioning like in echocardiographic lab, but also in subjects admitted to ICU due to ARDS needing of mechanical ventilation in prone positioning. © Springer Nature Switzerland AG 2020.Entities:
Keywords: Coronavirus; Echocardiography; Respiratory failure
Year: 2020 PMID: 32954211 PMCID: PMC7491596 DOI: 10.1007/s42399-020-00516-5
Source DB: PubMed Journal: SN Compr Clin Med ISSN: 2523-8973
Results
| COVID-19 patients ( | |||
|---|---|---|---|
| Age (years) | 61.7 ± 7.9 | ||
| Gender (male/female) | 7/1 | ||
| BSA (m2) | 2.1 ± 0.2 | ||
| Supine(1) | Prone(2) | ||
| Hemodynamics | |||
| MAP (mmHg) | 83 ± 12 | 78 ± 14 | 0.417 |
| HR (bpm) | 100 ± 28 | 100 ± 11 | 1.000 |
| ScvO2 (%) | 74 ± 4.8 | 77 ± 5.2 | 0.270 |
| CVP (mmHg) | 11 ± 2.1 | N/A | - |
| Norepinephrine (μg/kg/min) | 0.17 ± 0.1 | 0.22 ± 0.2 | 0.500 |
| Mechanical ventilation | |||
| pO2/FiO2 (mmHg) | 110 ± 19 | 121 ± 32 | 0.456 |
| PEEP (cmH2O) | 13 ± 3.0 | 15 ± 2.6 | 0.265 |
| | 34 ± 9.2 | 35 ± 11.7 | 0.780 |
| Echocardiography | |||
| RV end-diastolic diameter (mm) | 37 ± 5 | 35 ± 3 | 0.328 |
| LV end-diastolic diameter (mm) | 43 ± 4 | 44 ± 5 | 0.704 |
| RV/LV end-diastolic diameter ratio | 0.88 ± 0.1 | 0.81 ± 0.1 | 0.348 |
| TAPSE (mm) | 21 ± 3 | 21 ± 5 | 0.954 |
| S′ TDI tricuspid valve annulus (cm/s) | 16 ± 3.8 | 19 ± 9.3 | 0.398 |
| PAPs (mmHg) | 49 ± 9 | 41 ± 10 | 0.132 |
| LVOT VTI (cm) | 20.6 ± 4.9 | 25.6 ± 5.8 | 0.184 |
| LV ejection fraction (%) | 53 ± 4.6 | 54 ± 5.8 | 0.815 |
| MAPSE (mm) | 13 ± 1.9 | 16 ± 4.9 | 0.171 |
| IVC maximum diameter | 21 ± 2.9 | -* | |
| IVC distensibility index (%) | 25 ± 21 | -* | |
MAP, mean arterial pressure; HR, heart rate; ScvO, central venous oxygen saturation; CVP, central venous pressure; PEEP, positive end-expiratory pressure; C, compliance of the respiratory system; RV, right ventricle; LV, left ventricle; TAPSE, tricuspid annular plane systolic excursion; S′ TDI, systolic wave tissue Doppler imaging; PAPs, pulmonary artery systolic pressure; LVOT VTI, left ventricle outflow tract velocity-time integral; MAPSE, mitralic annular plane systolic excursion; IVC, inferior vena cava; N/A, not available
(1)Supine position: just before the prone positioning
(2)Prone position: ≥ 1 h after the prone positioning
*In prone position, the subcostal view is not accessible
Fig. 1TTEp technique and the A-4-C view
Fig. 2One case COVID-19 example of diameter ventricle ratio in supine and prone positioning echocardiography. a Echocardiography in supine positioning. b Echocardiography in prone positioning
Patients’ data after prone positioning and outcome
| Patient | TAPSE variation (%) | RVEDD variation (%) | PAPs variation (%) | ICU length of stay (days) | Outcome | ||
|---|---|---|---|---|---|---|---|
| 1 | − 5 | − 26 | 27 | 39 | − 17 | 90 | Alive |
| 2 | − 43 | − 3 | − 2 | − 26 | 9 | 12 | Dead |
| 3 | 53 | − 15 | 30 | − 26 | − 42 | 64 | Alive |
| 4 | 16 | − 3 | 22 | 22 | − 19 | 35 | Alive |
| 5 | − 22 | 3 | 9 | 68 | − 17 | 64 | Alive |
| 6 | − 9 | 0 | 7 | 14 | − 17 | 49 | Alive |
| 7 | − 13 | 9 | 4 | − 20 | − 23 | 24 | Alive |
| 8 | 42 | − 3 | − 24 | 0 | 0 | 66 | Alive |
TAPSE, tricuspid annular plane systolic excursion; RVEDD, right ventricle end-diastolic diameter; P/F, pO2/FiO2 ratio; C, compliance of the respiratory system; PAPs, systolic pulmonary artery pressure